5 iEdison Screen Shot Manage Utilization Report

PHS Research Performance Progress Report and Other Post-award Reporting (OD)

Attachment 16B iEdison Screen Shots_Manage Utilization Reports

iEdison

OMB: 0925-0002

Document [pdf]
Download: pdf | pdf
2/10/2015

iEdison: Manage Utilization Reports

NIH\SALZMANJ | John Salzman iEdison Accounts Administrator
Main Menu   Search Inventions   Search Patents   Search Utilization   Search Documents   Search iEdison Account

About   Help   Logout

Add Utilization Report 
All fields marked with an asterisk (*) are required. Fill out the fields below and then choose "Submit" to save your changes.
Reminder: This information is cumulative for all inventions that have had title elected or have been licensed without being patented, including any patents arising
from invention report number 7654321­03­0018. This utilization report is for the twelve month reporting period starting on the first day of the month that has been
selected for your institution.

     Utilization Report
Invention Title    New invention
Invention Report Number 7654321­03­0018
Grantee/Contractor Organization DAN'S INSTITUTION (7654321)
Reporting Year 2015
*Please indicate the latest stage of
development of any product arising from
­­Choose One­­
this invention, according to the following
categories:
If any product arising from this invention
has reached the market, what was the
calendar year of the first commercial sale?

 (YYYY)

In the designated reporting period, what
was the total income received as a result
of license or option agreements? Do not $ 0.00
include specific patent costs
reimbursement.
In the designated reporting period, did the
grantee organization/contractor or any of
the exclusive licensees request a waiver
of the U.S. manufacturing requirements?

Yes 
No

If yes, how many such waivers were
0
obtained?
Please provide the commercial name of
 
any FDA­approved products, utilizing this
invention, that have first reached the Please note: Commercial names should be limited to FDA­approved products that first reached the market during
market during the designated reporting the designated reporting period. Please remove the "Public" checkmark from any FDA­approved product that you do
period. not want to appear on a publicly available list of products arising from your funding agreement.
In the designated reporting period, how
many exclusive licenses and/or options 0
are active?
Number of Domestic Manufacturing
Licenses
In the designated reporting period, how
many non­exclusive licenses and/or 0
options are active?
In the designated reporting period, how
many licenses and/or options of any type
0
to small businesses (<500 employees) are
active?
Total Gross Sales $ 0.00
 

    

    

IEDISON­2806
Home | Main Menu | Change Password | About | Help | Logout 
E­mail the NIH administrator | OMB Burden Statement | iEdison Privacy Notice | Feedback/Suggestions for iEdison

https://public.era.nih.gov/iedison/UtilizationYearAction.do

1/1


File Typeapplication/pdf
File Modified2015-07-09
File Created2015-03-09

© 2024 OMB.report | Privacy Policy